
A Potential Treatment to Prevent Alzheimer’s
Charter Research is recruiting people at risk for Alzheimer’s disease to test whether a drug developed to slow the disease’s progression (donanemab) could potentially prevent it. If successful, the drug treatment would be a significant breakthrough in the fight against the disease.
Preliminary Qualifications
-
You are 55-80 years old.
-
You have normal thinking and memory.
-
You have a reliable study partner.